Zobrazeno 1 - 10
of 306
pro vyhledávání: '"H W, Reesink"'
Publikováno v:
Journal of Hepatology. 68:S757-S759
Autor:
T. Raison, Pascal Morel, Susanna Sainio, Paolo Rebulla, P. S. Prado Scuracchio, Eeva Juvonen, Hany Kamel, S. Wendel, D. Kientz, L. Qu, Miquel Lozano, H. W. Reesink, Darrell J. Triulzi, Gilles Delage, Joanne Pink, Joan O'Riordan, Arturo Pereira, M. Horvath, Ai Leen Ang, C. K. Lin, J. P. Cazenave, R. Pawson, X. Dongfu, Tom Krusius, Joan Cid, S. Waldvogel, Veerle Compernolle, P. Guntz, Peter Flanagan, Bengt Ekermo, G. Andreu, Susan Nahirniak, Stefano Fontana, Michael P. Busch, Christoph Niederhauser, Dana V. Devine, Michael J R Desborough, Lani Lieberman, Gerda Leitner, Janet Yuen Ha Wong, K. Hourfar, E. Raspollini, M. Li, Silvia Sauleda, Simon Panzer, S. Villa, Erhard Seifried, Sally Lam, S. Benson, D. Teo
Publikováno v:
Vox sanguinis, 107(3), 276-311. Wiley-Blackwell
L. Lieberman, D. V. Devine, H. W. Reesink, S. Panzer, J. Wong, T. Raison, S. Benson, J. Pink, G. C. Leitner, M. Horvath, V. Compernolle, P. S. Prado Scuracchio, S. Wendel, G. Delage, S. Nahirniak, X. Dongfu, T. Krusius, E. Juvonen, S. Sainio, J.-P. C
Autor:
H. W. Reesink, P. F. van der Meer
Publikováno v:
Vox Sanguinis. 113:499-500
Autor:
H. W. Reesink1 h.w.reesink@amc.nl, S. Panzer2 simon.panzer@meduniwien.ac.at, C. A. Gonzalez3 carlos.gonzalez@speedy.com.ar, N. Lena3, P. Muntaabski2, S. Gimbatti4, E. Wood5 woodericam@hotmail.com, M. Lambermont6 m.lambermont@redcross-transfusion.be, V. Deneys6, D. Sondag6, T. Alport7 Ted.alport@blood.ca, D. Towns8 Dale.towns@blood.ca, D. Devine9 Dana.devine@blood.ca, P. Turek10 petr.turek@ftn.cz, M.-K. Auvinen11 Marja-Kaisa.Auvinen@veripalvelu.fi, T. Koski12, C. K. Lin13 cklin@ha.org.hk, C. K. Lee13, W. C. Tsoi13, E. Lawlor14 emer.lawlor@ibts.ie
Publikováno v:
Vox Sanguinis. Oct2010, Vol. 99 Issue 3, p278-293. 16p. 1 Chart.
Autor:
Hitoshi Ohto, Gösta Berlin, S. Wendel, Z. Zhu, S. Engelbrecht, S. Biagini, P. Agarwal, Olivier Garraud, Teguh Triyono, Kyou-Sup Han, Merrole F Cole-Sinclair, N. Manny, Philippe Rouger, Jean-Jacques Lefrère, Harumi Fujihara, Kenneth E. Nollet, K. Janetzko, S. G. Sandler, V. S. Nadarajan, Anneke Brand, H. W. Reesink, Erica M. Wood, G. Andreu, Ronald G. Strauss, Michael Müller-Steinhardt, Ahmad Gharehbaghian, Simon Panzer, Akihiro Takeshita, P. van der Burg, T. Zunino, J.-J. Cabaud, Yuji Yonemura, O. Zelig
Publikováno v:
Vox Sanguinis. 104:250-272
S. Panzer, S. Engelbrecht, M. F. Cole-Sinclair, E. M. Wood, S. Wendel, S. Biagini, Z. Zhu, J.-J. Lefrere, G. Andreu, T. Zunino, J.-J. Cabaud, P. Rouger, O. Garraud, K. Janetzko, M. Muller-Steinhardt, P. van der Burg, A. Brand, P. Agarwal, T. Triyono,
Autor:
Minoko Takanashi, Hubert Schrezenmeier, Halvard Bonig, Simon Panzer, Johanna Nystedt, Dirk Strunk, Paolo Rebulla, Hermann Eichler, E. B. Austin, Katharina Schallmoser, Rosaria Giordano, Matti Korhonen, Luc Sensebe, H. W. Reesink, S. Fleury-Cappellesso, M. Guttridge, Lucilla Lecchi, Tanja Kaartinen, Suzanne M. Watt, L. S. McLaughlin
Publikováno v:
Vox Sanguinis. 104:67-91
Autor:
H. W. Reesink, Peter L.M. Jansen, G. Roosendaal, H. M. Van Den Berg, Evelien P. Mauser-Bunschoten, Dorine Bresters, R. A. F. M. Chamuleau, E. Haan
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 1(1)
To evaluate the effect and side-effects of alpha interferon 2B (IFN) treatment in haemophilia patients with chronic hepatitis C (positive HCV antibody test, positive HCV-RNA test and ALT levels >2.5 × upper limit of normal) eight HIV and HBs-ag nega
Autor:
L. Critelli, E. Cooney, E. Santagostino, Dong Xu, P. Bogomolov, S. Srinivasan, K. J. van Erpecum, A. Olveira, Stanislas Pol, H. W. Reesink
Publikováno v:
Haemophilia, 22(5), 692. Wiley-Blackwell
Haemophilia, 22(5), 692-699. Wiley-Blackwell
Haemophilia, 22(5), 692-699. Wiley-Blackwell
AIM: This study explores the potential role of a novel interferon-containing regimen for treatment of patients with chronic hepatitis C (CHC) and underlying haemophilia. METHODS: This trial (NCT01741545) was an open-label, non-randomized phase 3 stud
Autor:
Neeltje A. Kootstra, S.B. Willemse, H. W. Reesink, R.B. Takkenberg, Louis Jansen, M.J. Sinnige, Joanne Verheij, A. de Niet
Publikováno v:
Antiviral research, 131, 148-155. Elsevier
Interferon-y-inducible protein-10 (IP-10), also called CXCL10, is produced by different types of cells such as monocytes, neutrophils and hepatocytes. IP-10 functions as an inflammatory cytokine, which after binding to its receptor CXCR3, expressed o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3adccd57297e5631a3e18b9016f475cb
https://pure.amc.nl/en/publications/intrahepatic-ip10-mrna-and-plasma-ip10-levels-as-response-marker-for-hbeagpositive-chronic-hepatitis-b-patients-treated-with-peginterferon-and-adefovir(6412870a-6dff-4cf5-8b09-42ef97a4c7ab).html
https://pure.amc.nl/en/publications/intrahepatic-ip10-mrna-and-plasma-ip10-levels-as-response-marker-for-hbeagpositive-chronic-hepatitis-b-patients-treated-with-peginterferon-and-adefovir(6412870a-6dff-4cf5-8b09-42ef97a4c7ab).html
Autor:
M.J. Sinnige, F. Stelma, H.L.A. Janssen, Louis Jansen, Neeltje A. Kootstra, H. W. Reesink, K.A. van Dort, R.B. Takkenberg
Publikováno v:
Journal of viral hepatitis, 23(8), 652-659. Wiley-Blackwell
Journal of Viral Hepatitis, 23(8), 652-659. Wiley-Blackwell Publishing Ltd
Journal of Viral Hepatitis, 23(8), 652-659. Wiley-Blackwell Publishing Ltd
Current treatment for chronic hepatitis B infection (CHB) consists of interferon-based therapy. However, for unknown reasons, a large proportion of patients with CHB do not respond to this treatment. Hence, there is a pressing need to establish respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b5a1dd5a6a97eea4fecd8128b34267
https://pure.amc.nl/en/publications/hlac-and-kir-combined-genotype-as-new-response-marker-for-hbeagpositive-chronic-hepatitis-b-patients-treated-with-interferonbased-combination-therapy(066f17c0-f460-4185-9078-52ee135ccaaf).html
https://pure.amc.nl/en/publications/hlac-and-kir-combined-genotype-as-new-response-marker-for-hbeagpositive-chronic-hepatitis-b-patients-treated-with-interferonbased-combination-therapy(066f17c0-f460-4185-9078-52ee135ccaaf).html